Viewing nowMyungmoon Simvastatin Tablet
Simvastatin 20mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 200403243 · Notified 2004.09.30 · Insurance code 649801210
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
This medication reduces the risk of death from coronary heart disease, non-fatal myocardial infarction, and stroke in adult patients with a high risk of cardiovascular diseases, including coronary heart disease, diabetes, peripheral vascular disease, and stroke. Additionally, it lowers total cholesterol, bad LDL cholesterol, Apo-B protein, and triglyceride levels while increasing good HDL cholesterol levels in patients with primary hypercholesterolemia and dyslipidemia, thereby improving blood lipid levels. This medication is particularly effective in controlling cholesterol levels in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia who have insufficient control with diet alone. Therefore, it is useful for reducing cardiovascular disease risks and managing hyperlipidemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before treatment, the treatment target, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). 2) Refer to the information below for recommended doses in patients taking this medicine with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see Precautions for Use, 6. Drug Interactions). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatment (e.g., LDL apheresis), or when other lipid-lowering treatment is not available. (2) In older adults, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering medicines This medicine is effective when used alone or in combination with bile acid sequestrants. When this medicine is coadministered with fibrates (excluding gemfibrozil (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment Since this medicine is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, initiate treatment at 5 mg per day and monitor carefully.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dosage range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goals. Dose adjustments should be made at intervals of 4 weeks or longer.
This medication helps lower blood cholesterol levels. However, caution is required as there may be abnormalities in the muscles while taking this medication. The risk of muscle damage can increase, especially when taking high doses or in combination with certain medications. If symptoms such as muscle pain, tenderness, or weakness occur, notify a doctor immediately. Since this medication is primarily metabolized in the liver, patients with poor liver function or liver disease should not take it. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not take this medication. Additionally, this medication may be dangerous when taken with other drugs that act on the liver, such as certain antifungals, antibiotics, and immunosuppressants, so it is necessary to inform your doctor or pharmacist. Elderly patients, patients with reduced kidney function, and those with hypothyroidism should also exercise caution when taking this medication. Regular monitoring of liver function and muscle status is recommended while on this medication. Patients with a history of excessive alcohol use or liver disease should be especially careful. Rarely, side effects such as hepatitis, skin rashes, and thrombocytopenia may occur, so if any unusual symptoms arise, consult medical personnel immediately. Moreover, it is advisable to avoid certain beverages such as grapefruit juice while taking this medication. This medication can also be used in children and adolescents, but dosages and precautions vary depending on age and condition, so consultation with a specialist is necessary. Always inform medical personnel when starting any new medications while taking this medication, and do not discontinue or change it without consulting your doctor. Finally, keep this medication out of reach of children and store it in its original container.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius. Storing it this way will help ensure the medication's effectiveness.
Brownish-yellow oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.